Interventions to reduce weight gain in schizophrenia.
作者信息
Faulkner Guy, Cohn Tony, Remington Gary
机构信息
Faculty of Physical Education and Health, University of Toronto, Toronto, Canada.
出版信息
Schizophr Bull. 2007 May;33(3):654-6. doi: 10.1093/schbul/sbm022. Epub 2007 Apr 21.
Abstract
摘要
相似文献
1
Interventions to reduce weight gain in schizophrenia.
Schizophr Bull. 2007 May;33(3):654-6. doi: 10.1093/schbul/sbm022. Epub 2007 Apr 21.
2
The role of lifestyle interventions and weight management in schizophrenia.
J Psychopharmacol. 2005 Nov;19(6 Suppl):28-35. doi: 10.1177/0269881105058682.
3
Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
Aust N Z J Psychiatry. 2008 May;42(5):369-81. doi: 10.1080/00048670801961123.
4
Schizophrenia and obesity: impact of antipsychotic medications.
J Clin Psychiatry. 2004;65 Suppl 18:13-26.
5
Management of weight gain in patients with schizophrenia.
J Clin Psychiatry. 2002;63 Suppl 4:33-6.
6
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
J Clin Psychiatry. 2004;65 Suppl 7:4-18; quiz 19-20.
7
The clinical implications of weight gain in schizophrenia.
J Clin Psychiatry. 2001;62 Suppl 7:32-7.
8
Schizophrenia, obesity, and antipsychotic medications: what can we do?
Postgrad Med. 2008 Jul;120(2):18-33. doi: 10.3810/pgm.2008.07.1786.
9
Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
Issues Ment Health Nurs. 2009 Dec;30(12):803-5. doi: 10.3109/01612840903276712.
10
[Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Psychiatr Pol. 2007 Jul-Aug;41(4):457-72.
引用本文的文献
1
Alterations and potential associations of repetitive transcranial magnetic stimulation on body weight in stable schizophrenic patients.
Schizophrenia (Heidelb). 2025 Apr 28;11(1):72. doi: 10.1038/s41537-025-00621-1.
2
Evidence and gap map of studies assessing the effectiveness of interventions for people with disabilities in low-and middle-income countries.
Campbell Syst Rev. 2020 Jan 9;16(1):e1070. doi: 10.1002/cl2.1070. eCollection 2020 Mar.
3
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study.
Curr Neuropharmacol. 2023;21(2):417-423. doi: 10.2174/1570159X20666220524123315.
4
Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.
Cochrane Database Syst Rev. 2021 Feb 16;2(2):CD013281. doi: 10.1002/14651858.CD013281.pub2.
5
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.
Neuropsychiatr Dis Treat. 2017 Aug 22;13:2231-2241. doi: 10.2147/NDT.S113099. eCollection 2017.
6
Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness.
BMC Psychiatry. 2017 Mar 21;17(1):107. doi: 10.1186/s12888-017-1265-7.
7
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis.
PLoS One. 2017 Jan 5;12(1):e0168549. doi: 10.1371/journal.pone.0168549. eCollection 2017.
8
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.
Diabetes Obes Metab. 2017 Feb;19(2):162-171. doi: 10.1111/dom.12795. Epub 2016 Nov 14.
9
Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder.
BMC Res Notes. 2016 Jul 12;9:340. doi: 10.1186/s13104-016-2151-y.
10
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Neuropsychiatr Dis Treat. 2014 Jul 10;10:1287-96. doi: 10.2147/NDT.S60246. eCollection 2014.
Zotero 插件